Neurofilament is a type of filament that is required for the cytoskeleton of a neuron that supports the axon cytoplasm. The neurofilaments are the most common types of fibrillar component s that are available in the axon.
This report contains market size and forecasts of Anti Neurofilament L Antibody in Global, including the following market information:
Global Anti Neurofilament L Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti Neurofilament L Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mouse Anti Neurofilament L Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti Neurofilament L Antibody include Merck, BioLegend, Cell Signaling Technology, Rockland Immunochemicals, Bio-Rad Laboratories and EnCor Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti Neurofilament L Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti Neurofilament L Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti Neurofilament L Antibody Market Segment Percentages, by Type, 2021 (%)
Mouse Anti Neurofilament L Antibody
Rabbit Anti Neurofilament L Antibody
Others
Global Anti Neurofilament L Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti Neurofilament L Antibody Market Segment Percentages, by Application, 2021 (%)
Academic and Research Institutes
Pharma and Biotech Companies
Others
Global Anti Neurofilament L Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti Neurofilament L Antibody Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti Neurofilament L Antibody revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti Neurofilament L Antibody revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
BioLegend
Cell Signaling Technology
Rockland Immunochemicals
Bio-Rad Laboratories
EnCor Biotechnology